Cite

HARVARD Citation

    Canino, F. et al. (n.d.). P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial. Breast. pp. S60-. [Online]. 
  
Back to record